Traxis Partners’s AbbVie ABBV Stock Holding History

Traxis Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-40,000	Closed	-$1.65M	–	2
2013 Q2	$1.65M	Buy	+40,000	New	+$1.75M	1.28%	41

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Traxis Partners's ABBV Position: Q3 2013 in Review

Traxis Partners sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 40,000 shares — an estimated $1.65M sold.

Traxis Partners first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $1.65M in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

Traxis Partners reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 40,000 AbbVie shares in Q3 2013, an estimated $1.65M.
Traxis Partners first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
Traxis Partners's AbbVie position peaked at $1.65M in Q2 2013.
1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.